Viewing Study NCT05110157


Ignite Creation Date: 2025-12-24 @ 7:00 PM
Ignite Modification Date: 2026-02-09 @ 6:29 AM
Study NCT ID: NCT05110157
Status: COMPLETED
Last Update Posted: 2025-07-10
First Post: 2021-10-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Journey Study: Evaluate the Efficacy, Safety, and Tolerability of Valbenazine as Adjunctive Treatment for Schizophrenia
Sponsor: Neurocrine Biosciences
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module